Tokyo Tape
Sign in
← Cuc

Half-year report · HY

9158.TEDINET S100X3FV
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥26.3bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥47.0bn2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥21.6bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥1.7bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥3.0bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥1.4bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥5.2bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.2bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥612m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.1bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥566m2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥94.1bnat 2025-09-30Cons.Assets IFRS
Total assets¥85.2bnat 2025-03-31Cons.Assets IFRS
Total assets¥70.2bnat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥63.4bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥54.9bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥30.7bnat 2025-09-30Cons.Equity IFRS
Net assets / equity¥30.3bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥28.5bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥28.0bnat 2024-03-31vCons.Equity IFRS
Equity (owners)¥30.2bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥29.7bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥27.9bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥13.3bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥7.5bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥8.3bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥2.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥2.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥4.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥6.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.6bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥5.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥20.892025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥106.812024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥68.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥20.892025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥106.812024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥68.512024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio32.0%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio34.8%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.8%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30−¥10m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥226m
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥226m
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥454m
Hospicereportable segmentrevenue2025-04-01 → 2025-09-30¥7.9bn
Hospicereportable segmentrevenue external2025-04-01 → 2025-09-30¥7.9bn
Hospicereportable segmentsegment profit2025-04-01 → 2025-09-30¥139m
In Home Nursingreportable segmentrevenue2025-04-01 → 2025-09-30¥6.5bn
In Home Nursingreportable segmentrevenue external2025-04-01 → 2025-09-30¥6.5bn
In Home Nursingreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥3m
In Home Nursingreportable segmentsegment profit2025-04-01 → 2025-09-30¥657m
Management Supportreportable segmentrevenue2025-04-01 → 2025-09-30¥8.2bn
Management Supportreportable segmentrevenue external2025-04-01 → 2025-09-30¥8.0bn
Management Supportreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥223m
Management Supportreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
Medical Care Residencereportable segmentrevenue2025-04-01 → 2025-09-30¥3.8bn
Medical Care Residencereportable segmentrevenue external2025-04-01 → 2025-09-30¥3.8bn
Medical Care Residencereportable segmentsegment profit2025-04-01 → 2025-09-30−¥96m
—segment totalrevenue2025-04-01 → 2025-09-30¥26.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥26.3bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥226m
—segment totalsegment profit2025-04-01 → 2025-09-30¥2.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥26.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥26.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥226m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥55m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥439m
Hospicereportable segmentrevenue2024-04-01 → 2024-09-30¥6.7bn
Hospicereportable segmentrevenue external2024-04-01 → 2024-09-30¥6.7bn
Hospicereportable segmentsegment profit2024-04-01 → 2024-09-30¥690m
In Home Nursingreportable segmentrevenue2024-04-01 → 2024-09-30¥6.1bn
In Home Nursingreportable segmentrevenue external2024-04-01 → 2024-09-30¥6.1bn
In Home Nursingreportable segmentsegment profit2024-04-01 → 2024-09-30¥540m
Management Supportreportable segmentrevenue2024-04-01 → 2024-09-30¥8.9bn
Management Supportreportable segmentrevenue external2024-04-01 → 2024-09-30¥8.7bn
Management Supportreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥157m
Management Supportreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.2bn
—segment totalrevenue2024-04-01 → 2024-09-30¥21.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥21.5bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥21.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥3.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 851
ItemContextValueUnit
Refunds from investment inv cf IFRSPrior1InterimDuration－JPY
Refunds from investment inv cf IFRSInterimDuration25000000JPY
Other inv cf IFRSPrior1InterimDuration－JPY
Other inv cf IFRSInterimDuration0JPY
Net cash provided by used in investing activities IFRSPrior1InterimDuration-2024000000JPY
Net cash provided by used in investing activities IFRSInterimDuration-3397000000JPY
Proceeds from long term borrowings fin cf IFRSPrior1InterimDuration6960000000JPY
Proceeds from long term borrowings fin cf IFRSInterimDuration9700000000JPY
Repayments of long term borrowings fin cf IFRSPrior1InterimDuration-1175000000JPY
Repayments of long term borrowings fin cf IFRSInterimDuration-1406000000JPY
Repayments of lease obligations fin cf IFRSPrior1InterimDuration-660000000JPY
Repayments of lease obligations fin cf IFRSInterimDuration-1435000000JPY
Proceeds from issuance of share acquisition rights fin cf IFRSPrior1InterimDuration6000000JPY
Proceeds from issuance of share acquisition rights fin cf IFRSInterimDuration－JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1InterimDuration-33000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSInterimDuration－JPY
Capital contribution from non controlling interests fin cf IFRSPrior1InterimDuration－JPY
Capital contribution from non controlling interests fin cf IFRSInterimDuration22000000JPY
Net cash provided by used in financing activities IFRSPrior1InterimDuration5098000000JPY
Net cash provided by used in financing activities IFRSInterimDuration6881000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1InterimDuration-83000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSInterimDuration-58000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1InterimDuration4907000000JPY
Net increase decrease in cash and cash equivalents IFRSInterimDuration5791000000JPY
Cash and cash equivalents IFRSPrior2YearInstant8256000000JPY
Cash and cash equivalents IFRSPrior1YearInstant7533000000JPY
Cash and cash equivalents IFRSPrior1InterimInstant13163000000JPY
Cash and cash equivalents IFRSInterimInstant13324000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember8746000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember6705000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember6077000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember－JPY
Revenue from external customers IFRSPrior1InterimDuration_ReportableSegmentsMember21528000000JPY
Revenue from external customers IFRSPrior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember83000000JPY
Revenue from external customers IFRSPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember21611000000JPY
Revenue from external customers IFRSPrior1InterimDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1InterimDuration21611000000JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember157000000JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1InterimDuration_ReportableSegmentsMember157000000JPY
Intersegment revenue IFRSPrior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Intersegment revenue IFRSPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember157000000JPY
Intersegment revenue IFRSPrior1InterimDuration_ReconcilingItemsMember-157000000JPY
Intersegment revenue IFRSPrior1InterimDuration－JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000ManagementSupportReportableSegmentMember8903000000JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000HospiceReportableSegmentMember6705000000JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000InHomeNursingReportableSegmentMember6077000000JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E37214-000MedicalCareResidenceReportableSegmentMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass